Recent commentary has highlighted CRISPR Therapeutics’ expanding gene-editing pipeline, including cardiovascular candidates like CTX310 and CTX320 and programs in type 1 diabetes, alongside fresh Buy ...

What happened next may become the most important medical story of the decade. In just six months, a team at Children’s ...

Key market opportunities include advancements in research, medicine, diagnostics, and biotechnology through CRISPR. There is potential for innovative solutions and ethical exploration in gene editing, ...

Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...

British scientists used CRISPR to cut acrylamide in bread by lowering wheat asparagine, without yield loss, after successful field trials ...

A gene -edited wheat that produces toasted bread that is less carcinogenic has been developed by scientists.

Invasive species represent a $5.4 trillion global problem, with U.S. economic impact alone exceeding $500 billion annually.

The biotech revolution spent decades trying to harness power for medicine. The next chapter is harnessing it for everything ...

The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for ...

Humans have about 3 billion DNA bases in their genetic makeup. However, most of it does not encode for protein.

When CRISPR cuts a gene flanked by short, repeating DNA sequences, the cell’s repair machinery gets confused. It simply zips ...

In the first of a new series of GEN Keynote Webinars, Professor Rodolphe Barrangou, PhD (North Carolina State; EIC, The CRISPR Journal) offers a front-row perspective of the CRISPR revolution, the ...